Learn how comprehensive genomic profiling is advancing precision oncology and transforming cancer clinical trials.

Comprehensive genomic profiling (CGP) uses next-generation sequencing (NGS) to identify multiple genomic alterations that drive cancer growth, providing critical insights for biomarker discovery, patient stratification, and targeted therapy selection. This webinar explores how CGP is being applied to support precision medicine and improve oncology drug development.

Topics include:

• What comprehensive genomic profiling (CGP) is and how it differs from targeted genomic testing
• The four major classes of genomic alterations associated with cancer
• How CGP supports cancer diagnosis, biomarker identification, and precision medicine
• The role of CGP in optimizing oncology clinical trial design and enabling personalized therapies

As precision oncology continues to evolve, comprehensive genomic profiling is becoming an essential tool for guiding therapeutic development and clinical decision-making. Discover how CGP is helping researchers identify actionable biomarkers, improve patient selection, and accelerate the development of targeted cancer therapies.